NeuroD2 controls inhibitory circuit formation in the molecular layer of the cerebellum.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 02 2019
Historique:
received: 16 05 2016
accepted: 12 12 2018
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 19 8 2020
Statut: epublish

Résumé

The cerebellar cortex is involved in the control of diverse motor and non-motor functions. Its principal circuit elements are the Purkinje cells that integrate incoming excitatory and local inhibitory inputs and provide the sole output of the cerebellar cortex. However, the transcriptional control of circuit assembly in the cerebellar cortex is not well understood. Here, we show that NeuroD2, a neuronal basic helix-loop-helix (bHLH) transcription factor, promotes the postnatal survival of both granule cells and molecular layer interneurons (basket and stellate cells). However, while NeuroD2 is not essential for the integration of surviving granule cells into the excitatory circuit, it is required for the terminal differentiation of basket cells. Axons of surviving NeuroD2-deficient basket cells follow irregular trajectories and their inhibitory terminals are virtually absent from Purkinje cells in Neurod2 mutants. As a result inhibitory, but not excitatory, input to Purkinje cells is strongly reduced in the absence of NeuroD2. Together, we conclude that NeuroD2 is necessary to instruct a terminal differentiation program in basket cells that regulates targeted axon growth and inhibitory synapse formation. An imbalance of excitation and inhibition in the cerebellar cortex affecting Purkinje cell output may underlay impaired adaptive motor learning observed in Neurod2 mutants.

Identifiants

pubmed: 30723302
doi: 10.1038/s41598-018-37850-7
pii: 10.1038/s41598-018-37850-7
pmc: PMC6363755
doi:

Substances chimiques

Basic Helix-Loop-Helix Transcription Factors 0
Neurod2 protein, mouse 0
Neuropeptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1448

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS065920
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS113948
Pays : United States

Références

Genes Dev. 1999 Jul 1;13(13):1647-52
pubmed: 10398678
J Neurobiol. 1999 Nov 5;41(2):281-94
pubmed: 10512984
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):865-70
pubmed: 10639171
Nat Neurosci. 2000 Dec;3(12):1256-65
pubmed: 11100146
Dev Biol. 2001 Jun 1;234(1):174-87
pubmed: 11356028
Genesis. 2002 Aug;33(4):160-9
pubmed: 12203913
Neuron. 2003 Jun 5;38(5):785-96
pubmed: 12797962
Dev Biol. 2004 Jan 1;265(1):234-45
pubmed: 14697366
Cell. 2004 Oct 15;119(2):257-72
pubmed: 15479642
Brain Res. 2004 Nov 12;1026(2):168-78
pubmed: 15488478
J Physiol. 2005 Mar 1;563(Pt 2):369-78
pubmed: 15613376
Eur J Neurosci. 2005 Apr;21(8):2073-82
pubmed: 15869503
Genesis. 2005 Aug;42(4):247-52
pubmed: 16028233
Neuron. 2005 Jul 21;47(2):201-13
pubmed: 16039563
Neuron. 2005 Oct 6;48(1):17-24
pubmed: 16202705
Neuron. 2005 Oct 6;48(1):31-43
pubmed: 16202707
Mol Cell Biol. 2006 Jun;26(11):4311-5
pubmed: 16705180
Prog Neurobiol. 2006 Feb-Apr;78(3-5):272-303
pubmed: 16759785
Annu Rev Neurosci. 2006;29:1-35
pubmed: 16776578
Eur J Neurosci. 2006 Jul;24(2):466-78
pubmed: 16903854
J Neurosci. 2008 Jan 30;28(5):1140-52
pubmed: 18234892
Dev Biol. 2008 Oct 15;322(2):381-93
pubmed: 18721803
Trends Neurosci. 2009 Jan;32(1):30-40
pubmed: 18977038
Neuroscience. 2009 Sep 1;162(3):601-11
pubmed: 19166909
Methods Mol Biol. 2009;530:423-33
pubmed: 19266333
Cerebellum. 2009 Dec;8(4):477-89
pubmed: 19554387
Nat Neurosci. 2009 Aug;12(8):1042-9
pubmed: 19578381
Neuron. 2009 Jul 16;63(1):106-18
pubmed: 19607796
Nat Neurosci. 2010 Jan;13(1):133-40
pubmed: 20023653
Trends Neurosci. 2010 Apr;33(4):163-72
pubmed: 20138673
Trends Neurosci. 2010 Nov;33(11):524-32
pubmed: 20869126
Nat Rev Neurosci. 2011 Jun;12(6):327-44
pubmed: 21544091
J Neurosci. 2011 May 18;31(20):7365-79
pubmed: 21593321
J Neurosci. 2011 Jul 20;31(29):10463-73
pubmed: 21775592
Cerebellum. 2012 Jun;11(2):434-5
pubmed: 22090364
Neuron. 2012 Apr 26;74(2):384-96
pubmed: 22542190
J Neurosci. 2013 Jan 9;33(2):641-51
pubmed: 23303943
Curr Biol. 2013 May 20;23(10):850-61
pubmed: 23602477
Neuron. 2013 Jun 19;78(6):1050-62
pubmed: 23707614
Cell Mol Life Sci. 2013 Dec;70(24):4667-80
pubmed: 23811844
Dev Cell. 2013 Nov 11;27(3):278-92
pubmed: 24229643
J Neurosci. 2014 Apr 2;34(14):4786-800
pubmed: 24695699
Development. 2014 Jul;141(14):2791-5
pubmed: 25005474
Cerebellum. 2015 Oct;14(5):534-56
pubmed: 25599913
J Neuroendocrinol. 2015 Jun;27(6):435-45
pubmed: 25855519
Front Cell Neurosci. 2016 Nov 02;10:248
pubmed: 27853421
Brain Res. 1985 Feb 18;327(1-2):121-34
pubmed: 2985173
J Comp Neurol. 1972 Nov;146(3):335-54
pubmed: 4628749
Z Anat Entwicklungsgesch. 1972;136(2):224-48
pubmed: 5042759
Brain Res. 1978 Feb 3;141(1):1-19
pubmed: 624066
J Physiol. 1993 Aug;468:177-200
pubmed: 7504726
Acta Neuropathol. 1994;88(3):237-45
pubmed: 7810294
Nature. 1993 Mar 4;362(6415):65-7
pubmed: 8383297
Biochem Biophys Res Commun. 1996 Feb 15;219(2):526-30
pubmed: 8605021
Genes Dev. 1997 Sep 15;11(18):2323-34
pubmed: 9308961
Neuron. 1997 Sep;19(3):665-78
pubmed: 9331356
Nature. 1997 Nov 13;390(6656):169-72
pubmed: 9367153
J Neurosci. 1998 Feb 15;18(4):1408-18
pubmed: 9454850

Auteurs

Alexander Pieper (A)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.

Stephanie Rudolph (S)

Department of Neurobiology and Evelyn McKnight Brain Institute, University of Alabama at, Birmingham, AL, 35294, USA.
Department of Neurobiology, Harvard Medical School, Boston, MA, 02115, USA.

Georg L Wieser (GL)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.

Tilmann Götze (T)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.
Cellular Neurophysiology, Hannover Medical School, D-30625, Hannover, Germany.

Hendrik Mießner (H)

Cellular Neurophysiology, Hannover Medical School, D-30625, Hannover, Germany.

Tomoko Yonemasu (T)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.

Kuo Yan (K)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.
Charité-Universitätsmedizin Berlin, Institute of Cell Biology and Neurobiology, NeuroCure Cluster of Excellence, D-10115, Berlin, Germany.

Iva Tzvetanova (I)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.

Bettina Duverge Castillo (BD)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.

Ulli Bode (U)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.

Ingo Bormuth (I)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany.
Charité-Universitätsmedizin Berlin, Institute of Cell Biology and Neurobiology, NeuroCure Cluster of Excellence, D-10115, Berlin, Germany.

Jacques I Wadiche (JI)

Department of Neurobiology and Evelyn McKnight Brain Institute, University of Alabama at, Birmingham, AL, 35294, USA.

Markus H Schwab (MH)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany. schwab.markus@mh-hannover.de.
Cellular Neurophysiology, Hannover Medical School, D-30625, Hannover, Germany. schwab.markus@mh-hannover.de.
Center for Systems Neuroscience (ZSN), Hannover, Germany. schwab.markus@mh-hannover.de.

Sandra Goebbels (S)

Max-Planck-Institute of Experimental Medicine, D-37075, Goettingen, Germany. sgoebbels@em.mpg.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH